AstraZnca’spotntialmdicinfornuromylitisopticarcivsFDAOrphanDrugDsignation

AstraZncaanditsglobalbiologicsrsarchanddvlopmntarm,MdImmun,todayannouncdthatthUSFoodandDrugAdministration(FDA)hasgrantdOrphanDrugDsignationforthinvstigationalanti-CD19monoclonalantibody,MEDI-,forthtratmntofpatintswithnuromylitisoptica(NMO)aswllasnuromylitisopticaspctrumdisordrs(NMOSD).DvlopdbyMdImmun,MEDI-iscurrntlyinPhasIIbclinicaldvlopmntforNMO.

NMOisarar,lif-thratningautoimmundisasofthcntralnrvoussystminwhichthbody’simmunsystmattackshalthyclls,most







































白癜风治疗时间
寻常性白癜风


转载请注明:http://www.voikg.com//mjccwh/171610.html